Delcath Systems (DCTH) Announces Common, Warrants Offering

Delcath Systems, Inc. (Nasdaq: DCTH) has announced its intention to offer, subject to market and other conditions, shares of its common stock and warrants to purchase shares of common stock in an underwritten public offering. Delcath also expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock and warrants offered in the public offering to cover over-allotments, if any. The proceeds of the offering will primarily be used for general corporate purposes, including, but not limited to, commercialization of our products, obtaining regulatory approvals, funding of our clinical trials, research, capital expenditures and working capital.

Cowen and Company, LLC and Wedbush PacGrow Life Sciences are acting as joint book-runners for the offering. Roth Capital Partners is acting as co-manager for the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Gloo raises $22.75M in public stock offering at $3.25 per share
• Research Alliance Corporation IV prices $75M IPO on Nasdaq
• Haoxi Health closes $4M direct offering via Univest Securities